Source: Annual Congress 2004 - Inflammation and remodelling in human lungs
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. C. Van Leer, J. Zbaeren, M. Gugger, C. Obregon, V. Schroeder, L. P. Nicod, T. K. Geiser (Bern, Switzerland). Factor XIIIa is expressed in etiologically different fibrotic pulmonary lesions. Eur Respir J 2004; 24: Suppl. 48, 4181

Member's Comments

No comment yet.

Related content which might interest you: Inhalation of activated recombinant factor VII to treat pulmonary hemorrhage in a patient with cystic fibrosis Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF Source: Eur Respir J 2001; 17: 1220-1227 Year: 2001 Correlation between tenascin C and tissue factor in patients with interstitial lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 83s Year: 2003 B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Coagulation factor XII regulates inflammatory responses in human lungs Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury Year: 2017 The protease activated receptor (PAR)-2/tissue factor/coagulation factor VIIa axis in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 Expression of CD 34 and von Willebrand factor in pulmonary endothelium Source: Eur Respir J 2001; 18: Suppl. 33, 243s Year: 2001 Features of pulmonary involvement in patients with diffuse connective tissue diseases Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Fibroblastic foci in IPF are non-proliferative and express GATA-6 Source: Annual Congress 2010 - Cell biology and immunology of lung disease Year: 2010 ¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 P-Smad2 and α-SMA are co-localized in fibroblastic foci of human idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Airway cell biology Year: 2009 Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis Source: ERJ Open Res, 6 (4) 00347-2020; 10.1183/23120541.00347-2020 Year: 2020 Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Role of vascular endotelial growth factor polymorphisms in interstitial lung disease Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019